J&J's experimental RA drug has mixed results in clinical trial; Novartis reportedly considers buying generics maker; Donald Trump names healthcare transition team leader
Despite political rifts that have blocked progress on so many other fronts, Congress has managed to lay the groundwork for clear steps forward in mental health.
Policymakers respond to a crisis and every crisis has to have a villain. Unfortunately, today pharma is the villain.
Hillary Clinton releases drug-pricing plan; patent for Teva's Copaxone is invalidated; Roche's immunotherapy extends life
Walgreens Boots partners with PBM; Clinton proposes mental health plan; BI and Qualcomm to develop connected inhaler
Donald Trump and Hillary Clinton offer clear contrasts on the issues of the Affordable Care Act, entitlement reform, and drug pricing.
Presidential candidate Hillary Clinton said she would go after "predatory" pharma companies in new ad spot.
Clinton expecting to discuss drug prices; Turing criticized for raising the price of infectious-disease drug; online game helps patients reduce blood pressure
Sen. Hillary Clinton unveiled her healthcare plan, promising to cover all Americans if elected president - and taking a few swipes at the pharmaceutical and insurance industries.
Sens. Frist and Clinton are both on record as supporting the push for computerizing medical record keeping.
- Veeva and QuintilesIMS tussle over customer reference data
- What five different pharma marketing careers look like
- Five things for pharma marketers to know: Monday, March 27, 2017
- Five things for pharma marketers to know: Friday, March 24, 2017
- Five things for pharma marketers to know: Tuesday, March 28, 2017
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Digital IDs become focus as drugmakers seek to track doctors' behavior online
- Some CME experts remain skeptical when it comes to social media